Position in OCUL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,715,888
+$1,239,599 QoQ
Shares Held
785,732
+2.8% QoQ
Ownership
0.358%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#38
of 260 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Derivatives in OCUL
reported options exposure · as of Dec 31, 2023CallValue
$22,300
CallShares
5,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $187,106,390 across 112 Biotechnology names. OCUL ranks #5 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
78,107 | $38,798,090 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
1,140,476 | $9,984,867 | |
| 3 | EXEL |
Exelixis, Inc.
|
169,657 | $9,231,037 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,664 | $9,143,590 | |
| 5 | OCUL |
Ocular Therapeutix, Inc
This page
|
785,732 | $7,715,888 | |
| 6 | ARGX |
Argenx SE
|
7,844 | $7,277,427 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
184,543 | $7,199,022 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,196 | $6,982,691 |
All Filings in OCUL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,715,888 | 785,732 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $6,476,289 | 764,615 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $8,771,635 | 722,540 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,347,431 | 714,066 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,546,167 | 705,406 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $5,287,598 | 721,364 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $6,181,593 | 723,840 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,259,632 | 719,498 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,055,060 | 739,044 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $6,606,509 | 725,990 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $22,300 | 5,000 | Call | Sole | 2024-02-13 | |
| 2023-12-31 | $3,016,744 | 676,400 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,915,714 | 610,100 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,500 | 15,000 | Call | Sole | 2023-08-10 | |
| 2023-06-30 | $3,154,050 | 611,250 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,168,060 | 601,150 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,672,512 | 595,200 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,000 | 5,000 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $2,508,882 | 604,550 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,408,583 | 599,150 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,805,412 | 566,750 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,539,017 | 507,750 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $69,700 | 10,000 | Call | Sole | 2022-02-14 | |
| 2021-09-30 | $4,321,000 | 432,100 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||